Technical Analysis for LNTH - Lantheus Holdings, Inc.

Grade Last Price % Change Price Change
A 21.85 1.44% 0.31
LNTH closed up 1.44 percent on Thursday, April 22, 2021, on approximately normal volume. The bulls were able to push the stock to a new 52-week high.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Up
Historical LNTH trend table...

Date Alert Name Type % Chg
New 52 Week Closing High Bullish 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
New 52 Week High Strength 0.00%
20 DMA Support Bullish 1.44%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 1.44%
Bollinger Band Squeeze Range Contraction 1.44%
Outside Day Range Expansion 1.44%
Stochastic Sell Signal Bearish 3.46%
20 DMA Support Bullish 3.46%
Bollinger Band Squeeze Range Contraction 3.46%
Older End-of-Day Signals for LNTH ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
60 Minute Opening Range Breakout about 16 hours ago
New 52 Week High about 18 hours ago
Up 2% about 18 hours ago
Up 1% about 18 hours ago
Non-ADX 1,2,3,4 Pullback Entry about 18 hours ago
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Lantheus Holdings, Inc. Description

Lantheus Holdings, Inc. is engaged in developing, manufacturing, selling and distributing diagnostic medical imaging agents and products that assist clinicians in the diagnosis of cardiovascular and other diseases. The Company's medical imaging agents are used to diagnose coronary artery disease, congestive heart failure, stroke, peripheral vascular disease and other diseases. The Company's products include contrast agents and medical radiopharmaceuticals, including technetium generators. The Company's products include DEFINITY, TechneLite, Xenon Xe 133 Gas, Cardiolite, Neurolite, Thallium Tl 201, Gallium Ga 67, Gludef, Quadramet and Ablavar. The Company is also engaged in developing agents, such as Flurpiridaz F 18, which is a myocardial perfusion imaging agent; 18F LMI 1195, which is a cardiac neuronal imaging agent, and LMI 1174, which is a vascular remodeling imaging agent.


Classification

Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Medicine Diseases Chemical Elements Medical Imaging Heart Failure Stroke Medical Physics Artery Artery Disease Perfusion Neuron Elite Coronary Artery Disease Gallium Imaging Agent Peripheral Vascular Disease Congestive Heart Failure Radiopharmaceuticals Cardiovascular And Other Diseases Medicinal Radiochemistry Myocardial Perfusion Imaging

Is LNTH a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 22.11
52 Week Low 10.52
Average Volume 516,674
200-Day Moving Average 15.42
50-Day Moving Average 20.10
20-Day Moving Average 21.11
10-Day Moving Average 21.35
Average True Range 0.66
ADX 15.78
+DI 28.77
-DI 20.64
Chandelier Exit (Long, 3 ATRs ) 20.13
Chandelier Exit (Short, 3 ATRs ) 21.30
Upper Bollinger Band 22.30
Lower Bollinger Band 19.93
Percent B (%b) 0.81
BandWidth 11.20
MACD Line 0.49
MACD Signal Line 0.52
MACD Histogram -0.0313
Fundamentals Value
Market Cap 1.46 Billion
Num Shares 66.9 Million
EPS 0.01
Price-to-Earnings (P/E) Ratio 2731.25
Price-to-Sales 1.87
Price-to-Book 1.71
PEG Ratio 0.61
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 22.87
Resistance 3 (R3) 22.84 22.48 22.70
Resistance 2 (R2) 22.48 22.22 22.49 22.64
Resistance 1 (R1) 22.16 22.06 22.32 22.19 22.59
Pivot Point 21.80 21.80 21.88 21.81 21.80
Support 1 (S1) 21.48 21.54 21.64 21.51 21.11
Support 2 (S2) 21.12 21.38 21.13 21.06
Support 3 (S3) 20.80 21.12 21.00
Support 4 (S4) 20.83